CANF
Can-Fite BioPharma
CANF
CANF
12 hedge funds and large institutions have $1.52M invested in Can-Fite BioPharma in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
12
Holders Change
+1
Holders Change %
+9.09%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
AC
1
Armistice Capital
New York
|
$1.31M |
2 |
TSS
2
Two Sigma Securities
New York
|
$59.4K |
3 |
3
Wells Fargo
San Francisco,
California
|
$5.03K |
4 |
![]()
4
RhumbLine Advisers
Boston,
Massachusetts
|
$34.1K |
Top Sellers
1 |
1
Morgan Stanley
New York
|
$102K |
2 |
HF
2
HRT Financial
New York
|
$0 |
3 |
VF
3
Virtu Financial
New York
|
$0 |